Actas espanolas de psiquiatria · 2020
Brief day hospital mentalization based group psychotherapy for schizophrenia spectrum disorders: A feasibility study.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lana Fernando, Martí-Bonany Josep, Sanz-Correcher Pedro, Pérez Víctor, Irimia Andrea
Аннотация
BACKGROUND: Mentalization-based therapy (MBT), a manualized psychodynamically and developmentally oriented psychotherapy, has been proven effective in controlled studies in non-psychotic patients with severe mental disorders. Although MBT is currently being used to treat schizophrenia spectrum disorders (SSD), to date no prospective studies have evaluated outcomes and treatment-related adverse effects. Brief mentalization-based group psychotherapy (B-MBGT) is a 12-week program based on the explicit mentalizing techniques of MBT. The study was conducted at a day hospital (DH) and the main objective was to examine the feasibility of B-MBGT to treat patients with SSD.
METHOD: Open study to assess the safety of B-MBGT in 72 patients who met DSM-IV criteria for schizophrenia, schizophreniform disorder, schizoaffective disorder, or unspecified psychotic disorder. All patients underwent both B-MBGT and Integrated Psychological Therapy (IPT). Consequently, a secondary aim was to compare these two therapies in terms of acceptance and subjective efficacy.
RESULTS: Adverse reactions were scarce and the most common of the reported ones, discomfort during the group treatment session, was considered mild in most cases. Compared to IPT, B-MBGT yielded significant higher scores on four subjective efficacy parameters.
CONCLUSION: B-MBGT in DH is both feasible and safe in SSD patients and most patients in this study considered B-MBGT to be beneficial. Controlled studies are needed to determine the effectiveness of B-MBGT.
METHOD: Open study to assess the safety of B-MBGT in 72 patients who met DSM-IV criteria for schizophrenia, schizophreniform disorder, schizoaffective disorder, or unspecified psychotic disorder. All patients underwent both B-MBGT and Integrated Psychological Therapy (IPT). Consequently, a secondary aim was to compare these two therapies in terms of acceptance and subjective efficacy.
RESULTS: Adverse reactions were scarce and the most common of the reported ones, discomfort during the group treatment session, was considered mild in most cases. Compared to IPT, B-MBGT yielded significant higher scores on four subjective efficacy parameters.
CONCLUSION: B-MBGT in DH is both feasible and safe in SSD patients and most patients in this study considered B-MBGT to be beneficial. Controlled studies are needed to determine the effectiveness of B-MBGT.